Financials
- Market Capitalization 5.61 B
- Employee 433
- Founded 2018
- CEO N/A
- Website www.mirumpharma.com
- Headquarter Delaware, United States
- FIGI BBG00MH7T2M7
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-168.06
Rapporto prezzo/fatturato
7.61
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1162 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 306.68 USD | +1.61% | -0.40% | +7.63% | +63.89% | 6.11 B USD | ||
| 1177 | IMVT Immunovant, Inc. - Common Stock | 28.94 USD | -5.02% | -13.53% | -22.31% | +50.65% | 5.98 B USD | ||
| 1246 | ERAS Erasca, Inc. - Common Stock | 15.55 USD | -2.99% | +6.65% | -2.63% | +542.56% | 5.44 B USD | ||
| 1267 | PTCT PTC Therapeutics, Inc. - Common Stock | 63.24 USD | -2.26% | -1.19% | -5.61% | -4.83% | 5.28 B USD |